The Physicians Committee for Responsible Medicine applauds the Food and Drug Administration’s newly released draft guidance, ...
Patient-centric evidence, such as PROs and RWE, offers insights into patients' needs, enhancing drug development beyond traditional endpoints. Challenges include increased complexity and regulatory ...
Pharmaceutical Technology on MSN
FDA steps back from preclinical primate testing amid wider regulatory shift
New non-primate draft guidance follows the agency’s wider aim to curtail the use of animal testing in preclinical toxicology.
Rare disease research faces complex regulations, small patient populations, and high costs. As traditional incentives wane, ...
AGC Biologics is partnering with ATUM to integrate technology designed to increase yields and shorten the path to clinical trials.
In a university lab, an AI system generated millions of novel molecules to fight drug-resistant infections. And they're ...
Hank Green talks with us about why research and development make the prescription drug development process long...
Drug-resistant tuberculosis (DR-TB) heavily contributes to the global challenge of antimicrobial resistance (AMR), resulting ...
The convergence of genomics, systems biology, and artificial intelligence is transforming the landscape of drug discovery. Modern genomic technologies now ...
To soften the blow, CSPC has accelerated its shift from generic drugs to innovative medicines. In the first three quarters, ...
Natural products (NPs) have been an important source of drug discovery and development due to their novel structures and wide ...
In this interview, Kalpana Barnes highlights how new approach methodologies are addressing the gaps in drug discovery studies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback